Biopharma deal-making is on the rise again and now is the time for biopharma companies to embrace M&As to prepare for future growth.
Dr. Bethany Valente
Advertisement
Dr. Bethany Valente is the founder and managing partner of Tempo7 LLC.
Articles by Dr. Bethany Valente
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
2
Report: FDA to Change Vaccine Approval Process Based on Agency’s Claim of Covid Vaccine-Related Deaths
3
Korea and Australia's P&MA Shift: From Local Launch Opportunities to Regional Blueprint
4
Pharmaceutical Executive Daily: U.S. & U.K. Agree to 0% Tariffs on Pharmaceutical Products
5
